AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Orva 850mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Astonea Labs Private Limited

Salt Composition

Metformin (850mg)

Overview Orva 850mg Tablet SR

Metformin 850mg Extended-Release tablets manage type 2 diabetes by regulating blood glucose, mitigating the risk of associated complications. This medication also treats Polycystic Ovary Syndrome (PCOS) in women. For optimal absorption and reduced gastrointestinal upset, ingest with food, consistently at the same time daily. Discontinue use only under physician guidance. Maintaining a prescribed diet and exercise regimen is crucial for effective diabetes control. Common side effects include diarrhea, nausea, vomiting, gas, fatigue, dyspepsia, stomach discomfort, headache, and anorexia. Concurrent use with other antidiabetic medications, alcohol, or missed meals may lead to hypoglycemia (low blood sugar). Regular blood glucose monitoring is essential. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals require physician consultation. Renal function tests will be conducted before initiating therapy. Limit alcohol consumption to minimize potential side effects.

Primary Ingredients of Orva 850mg Tablet SR

No text provided to rephrase.

Uses of Orva 850mg Tablet SR

Management of type 2 diabetes and polycystic ovary syndrome

Major Benefits of Orva 850mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Orva 850mg Tablet SR. Ingest the tablet whole; do not break, crush, or chew it. This medication should be administered with food.

Common Side effects of Orva 850mg Tablet SR:

  • Diarrhea
  • Headache
  • Vomiting
  • Nausea
  • Flatulence
  • Abdominal discomfort
  • Weakness

How to use Orva 850mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Orva 850mg Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this medication with food.

How Orva 850mg Tablet SR works:

Sustained-release Orva 850mg tablets are a biguanide-class antidiabetic drug. Their mechanism involves reducing hepatic glucose output, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Orva 850mg SR tablets with alcohol is not advisable due to safety concerns.

PregnancyPregnancySAFE IF PRESCRIBED

The extended-release Orva 850mg tablet is typically deemed safe for use during pregnancy. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; however, clinical data from human studies are scarce.

Breast feedingBreast feedingCAUTION

Extended-release Orva 850mg tablets require careful consideration when breastfeeding. Mothers should discontinue breastfeeding throughout their treatment and until the medication is fully cleared from their system.

DrivingDrivingCAUTION

Driving may be impaired by excessively high or low blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with impaired kidney function should exercise caution when using Orva 850mg SR tablets, as dosage modification may be necessary. Consult a physician for guidance. Orva 850mg SR tablets are contraindicated in individuals with severely compromised kidney function.

LiverLiverUNSAFE

The extended-release Orva 850mg tablet is likely unsafe for individuals with hepatic impairment and its use should be avoided. Medical advice is recommended.

What if you forget to take Orva 850mg Tablet SR :

Should you forget to take your Orva 850mg Tablet SR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Orva 850mg Tablet SR

LabelValue
Type of Compound Guanidine-based compound
Potential for Dependence None.
Type of Medication Medication for diabetes

FAQs on Orva 850mg Tablet SR

Individuals with type 2 diabetes exhibit impaired responsiveness to endogenous insulin. Consequently, blood glucose levels elevate. Orva 850mg Tablet SR employs a multifaceted approach to lower hyperglycemia. This medication reduces hepatic glucose output, diminishes intestinal glucose absorption postprandially, and enhances insulin sensitivity in peripheral tissues. This combined action facilitates improved glucose uptake from the bloodstream and augments the body's natural insulin response.
Individuals overweight or obese taking Orva 850mg Tablet SR have demonstrated weight reduction. This medication may also induce modest weight loss in overweight or obese individuals predisposed to diabetes, as well as those with insulin sensitivity or resistance. However, self-initiation of Orva 850mg Tablet SR for weight loss is inadvisable; physician consultation is necessary.
Among the initial treatments for elevated blood glucose, Orva 850mg Tablet SR effectively manages blood sugar. This medication enhances the body's insulin utilization, reduces hepatic glucose production, and limits intestinal glucose absorption. Differing from other oral antidiabetic agents, Orva 850mg Tablet SR monotherapy infrequently leads to hypoglycemia by mitigating excessive pancreatic insulin release. Beyond glycemic control, it also aids in weight management.
Orva 850mg sustained-release tablets generally don't induce drowsiness and are typically well-received. Infrequently, however, Orva 850mg SR tablets may lead to sleep disturbances or insomnia. Drowsiness can be a symptom of a severe adverse reaction known as lactic acidosis, especially if renal function is impaired. Consult your physician if fatigue or somnolence develops during Orva 850mg SR treatment.
Administer Orva 850mg Tablet SR orally, with or following a meal. Avoid crushing or chewing the tablets; ingest them whole with water. For once-daily prescriptions, consume the tablet in the morning with breakfast. For twice-daily prescriptions, take one tablet with breakfast and the other with dinner. For thrice-daily regimens, distribute doses among breakfast, lunch, and dinner. Consuming Orva 850mg Tablet SR with food mitigates potential gastrointestinal distress, including indigestion, nausea, vomiting, diarrhea, abdominal pain, and anorexia.
Individuals diagnosed with type 2 diabetes either produce insufficient insulin or exhibit impaired responsiveness to their body's naturally produced insulin. This results in elevated blood sugar levels (hyperglycemia). Orva 850mg Tablet SR employs a multifaceted approach to lower these elevated blood glucose levels. Specifically, it reduces hepatic glucose production, diminishes intestinal glucose absorption postprandially, and enhances insulin sensitivity in bodily tissues. This combined action facilitates improved glucose uptake from the bloodstream and optimized responsiveness to endogenous insulin.
Orva 850mg SR tablets have demonstrated weight reduction in overweight and obese patients. This weight loss effect may also be observed in overweight and obese individuals predisposed to diabetes. Furthermore, individuals with insulin sensitivity or resistance may experience weight loss. However, self-initiation of Orva 850mg SR for weight management is discouraged; physician consultation is mandatory.
Among the initial treatments for elevated blood glucose, Orva 850mg Tablet SR effectively manages blood sugar. This medication enhances the body's insulin utilization, reduces hepatic glucose production, and limits intestinal glucose absorption. Differing from other oral antidiabetic agents, Orva 850mg Tablet SR, when used independently, infrequently results in hypoglycemia by modulating pancreatic insulin release. Beyond glycemic control, this medication also aids in weight management.
Orva 850mg extended-release tablets generally do not induce drowsiness and are typically well-received. Infrequently, though, Orva 850mg extended-release tablets may result in sleep disturbances or insomnia. Drowsiness can be a symptom of a severe adverse reaction known as lactic acidosis, especially if renal function is impaired. Seek medical attention if fatigue or sleepiness develops during Orva 850mg extended-release tablet treatment.
Administer Orva 850mg sustained-release tablets with or following a meal. Avoid crushing or chewing; ingest whole with water. For once-daily prescriptions, consume with breakfast. For twice-daily regimens, take one tablet with breakfast and the second with dinner. Three times daily, distribute doses with breakfast, lunch, and dinner. Consuming Orva 850mg SR tablets with food mitigates potential gastrointestinal distress, including indigestion, nausea, vomiting, diarrhea, abdominal pain, and anorexia.
Individuals with type 2 diabetes either produce insufficient insulin or exhibit impaired responsiveness to their naturally produced insulin. This leads to elevated blood glucose levels. Orva 850mg Tablet SR works through multiple mechanisms to lower these high blood sugar levels. Specifically, it reduces hepatic glucose production, diminishes intestinal glucose absorption following meals, and enhances insulin sensitivity in tissues and organs. This combined action promotes improved glucose uptake from the bloodstream and facilitates a more effective response to endogenous insulin.
Weight loss has been observed in overweight and obese individuals using Orva 850mg Tablet SR. This effect may also be seen in those with a predisposition to diabetes. Furthermore, insulin-resistant or insulin-sensitive patients might experience weight reduction. However, self-prescribing Orva 850mg Tablet SR for weight management is strongly discouraged; always seek medical advice before initiating treatment.
Orva 850mg Tablet SR is an initial treatment option for individuals with elevated blood glucose. This medication manages blood sugar by enhancing the body's insulin response, reducing hepatic glucose production, and limiting intestinal glucose absorption. Differing from other oral hypoglycemics, Orva 850mg Tablet SR, when administered independently, infrequently leads to hypoglycemia due to its inhibition of excessive insulin release. Beyond glycemic control, it also aids in weight management.
Orva 850mg sustained-release tablets generally do not induce drowsiness and are typically well-received. Infrequently, however, Orva 850mg sustained-release tablets may lead to sleep disturbances or insomnia. Somnolence can be a symptom of a severe adverse reaction known as lactic acidosis, especially if renal function is compromised. Seek medical advice if fatigue or sleepiness develops during Orva 850mg sustained-release tablet treatment.
Administer Orva 850mg Tablet SR orally, with or following a meal. The tablet should be swallowed whole with water; do not crush or chew. For once-daily regimens, consume the tablet in the morning with breakfast. Twice-daily prescriptions should be divided, with one dose taken in the morning and the second in the evening with dinner. Three times daily, take the medication with breakfast, lunch, and dinner. Consuming Orva 850mg Tablet SR with food mitigates potential gastrointestinal discomfort, including indigestion, nausea, vomiting, diarrhea, abdominal pain, and anorexia.
Orva 850mg Tablet SR
39
MRP 47
17% off